Navigation Links
Bluestar Silicones to Present Antimicrobial Silicones at Medical Silicones Conference in Boston

EAST BRUNSWICK, N.J., Sept. 27, 2011 /PRNewswire/ -- Bluestar Silicones Senior Scientist Dr. Olga Hoy, Ph.D., will present "Silicone Material to Control Bacterial Growth" at the upcoming Medical Silicones Conference in Boston, October 4-5.

According to Dr. Hoy, the rising number of hospital acquired infections, increasing cost of medical care and the aging population are factors that contribute to growing demand for medical devices and consumer goods that incorporate antimicrobial properties.

In her presentation, Dr. Hoy will explore the various factors medical device and consumer goods companies should consider in their quest for antimicrobial silicone materials.  From additive selection, to additive interaction with the silicone, to manufacturing process, to regulatory considerations, Dr. Hoy will demonstrate how a customized approach enables manufacturers to optimize the use of antimicrobials.

As a gold sponsor of the Medical Silicones Conference, Bluestar Silicones will host a tabletop display at the event highlighting its Silbione® brand adhesive silicone materials designed specifically for healthcare and medical applications.  For more information about Bluestar Silicones, call 1-866-474-6342.

About Dr. HoyDr. Olga Hoy is a senior scientist at Bluestar Silicones where she has been focused on antimicrobial silicones for the last 3 years.  She holds a Ph.D. in material sciences and engineering from Clemson University, Clemson, S.C., and an M.S. degree in pharmaceutical technology from Lviv Polytechnic National University, Lviv, Ukraine.

About Bluestar SiliconesWith worldwide operations headquartered in Lyon, France, Bluestar Silicones is a $650 million worldwide silicones raw material manufacturer.  Bluestar is one of the world's leading fully integrated global silicones manufacturers with more than 50 years of silicone expertise. Bluestar has manufacturing operations throughout the world and offers a comprehensive range of silicone technologies in support of diverse specialty markets including paper release, textile coatings, healthcare, moldmaking, automotive, aerospace and personal care.  For more information, call (866) 474-6342 or visit Contact: Karen O'Keefe, (732)

SOURCE Bluestar Silicones
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
10. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):